Hikma Pharmaceuticals PLC (LSE:HIK) - Share price - Overview

Stock Report

Hikma Pharmaceuticals PLC HIK

Last Price
GBX2,000.00

Day Change
-1.00|-0.05%

As of 27/03/2017
17:03:50 BST | GBX
Minimum 15 Minutes Delay.

Last Close2,001.00p
Day Range1,990.00 - 2,006.00
Mkt Cap4.80Bil
52-Wk Range1,575.00 - 2,703.00
Yield %1.15
ISINGB00B0LCW083
Volume1,178,227
P/E26.34
P/S4.09
P/CF18.43

Share Price

Total Returns 24/03/2017

 Chg (%)  
More ...
Hikma Pharmaceuticals PLC-5.12 
FTSE 100 TR GBP1.52
 
Financials
201420152016
More ...
Income Statement
Turnover906.03971.99-
Operating Profit244.61257.17-
Net Profit171.59171.45-
Reported EPS84.5884.64-
Balance Sheet
Current Assets650.84917.99-
Non Current Assets795.39834.97-
Total Assets1,446.231,752.95-
Current Liabilities540.33399.60-
Total Liabilities664.97840.37-
Total Equity781.26912.59-
Cash Flow
Operating Cash Flow306.67281.47-
Net Change in Cash68.76189.67-
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2017357.88110.0944.9818.180.4028.181.41
2018396.53123.8212.4816.161.3028.701.43

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/12/2016Transfer OutMr. Mazen Darwazah0.005,449,7160.00
19/12/2016PurchaseMr. Mazen Darwazah1,790.0050,000895,000.00
19/12/2016PurchaseMohammed Ali Al-Husry1,790.0050,000895,000.00
19/12/2016PurchaseMr. Said Darwazah1,790.0050,000895,000.00

Company Profile

Hikma Pharmaceuticals PLC is engaged in the development, manufacture and marketing of broad range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms.

Sector

Drug Manufacturers - Specialty & Generic

Market Position

96 of 1853 Companies

Index

FTSE 100 ,FTSE 350 ,FTSE All Share

Outlook

(15/03/2017) ceo - "...we are confident the future prospects of the group"

Next Event 06/04/2017

Ex Dividend
Ratios
CompSecMkt
More ...
PER (E)17.6814.4416.15
Div Yld (E)1.413.684.12
PEG (E)0.500.301.01
ROCE0.00180.55121.20
Op Mrgn0.00-11.48-8.23
EPS Grwth35.2685.6736.58
Dividends
PreviousLatest
More ...
Record Date02/09/1607/04/17
Ex-Div01/09/1606/04/17
Paid30/09/1625/05/17
Amnt8.4517.91

Broker Sentiment

Strong Buy0
Buy3
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
Chairman & Chief Executive OfficerMr. Said Darwazah
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.